Morphological studies on mixed growth hormone (GH)- and prolactin (PRL)-secreting human pituitary adenomas. Coexistence of GH and PRL in the same secretory granule
- PMID: 3084531
- DOI: 10.1210/jcem-62-6-1093
Morphological studies on mixed growth hormone (GH)- and prolactin (PRL)-secreting human pituitary adenomas. Coexistence of GH and PRL in the same secretory granule
Abstract
A morphological study was carried out on five mixed GH- and PRL-secreting pituitary adenomas, surgically removed from acromegalic patients with hyperprolactinemia, in order to verify whether the two hormones were contained in the same cell or in different cells. Double labeling with the protein A-gold immunotechnique was used to visualize the ultrastructural localization of the two hormones on ultrathin sections of the tumors. By means of this high resolution technique we found in all adenomas the presence of numerous (from 50-80% of the whole cell population) mammosomatotrophs, i.e. cells containing simultaneously PRL and GH. The occurrence of cells producing only GH (in four tumors) or only PRL (in one tumor) was also observed. In mixed cells GH and PRL were segregated in the same mixed granule. In one tumor granules positive only for GH together with mixed granules were found in the same cell. Immunofluorescence studies, at the light microscopic level, allowed us to clearly identify mammosomatotrophs only in two tumors. Double labeling using the gold immunotechnique appears therefore to be the most suitable experimental approach to detect the existence of mixed cells in plurihormonal adenomas. Our results support the idea that the frequency of mixed adenomas with mixed cells may be higher than that believed previously. The simultaneous presence of two hormones in the same secretory granule could explain why, in patients having mixed tumors, factors able to stimulate or inhibit the release of one hormone can also stimulate or inhibit the secretion of the other.
Similar articles
-
Ultrastructural study of mixed growth hormone & prolactin secreting pituitary adenomas.Indian J Med Res. 1992 Aug;96:209-14. Indian J Med Res. 1992. PMID: 1428057
-
Growth hormone and prolactin secretion in acromegaly: correlations between hormonal dynamics and immunocytochemical findings.J Clin Endocrinol Metab. 1988 Dec;67(6):1195-204. doi: 10.1210/jcem-67-6-1195. J Clin Endocrinol Metab. 1988. PMID: 3142915
-
Hormone secretion in vitro by plurihormonal pituitary adenomas of the acidophil cell line.J Clin Endocrinol Metab. 1992 Jul;75(1):68-75. doi: 10.1210/jcem.75.1.1352308. J Clin Endocrinol Metab. 1992. PMID: 1352308
-
[Classification of pituitary adenomas in terms of immunohistochemistry and ultrastructure].No Shinkei Geka. 1986 Mar;14(4):479-90. No Shinkei Geka. 1986. PMID: 3012389 Review. Japanese. No abstract available.
-
Pituitary adenoma producing growth hormone and adrenocorticotropin: a histological, immunocytochemical, electron microscopic, and in situ hybridization study. Case report.J Neurosurg. 1998 Jun;88(6):1111-5. doi: 10.3171/jns.1998.88.6.1111. J Neurosurg. 1998. PMID: 9609310 Review.
Cited by
-
Ultrastructural and electron immunohistochemical features of medullary thyroid carcinoma.Virchows Arch A Pathol Anat Histopathol. 1989;414(5):375-84. doi: 10.1007/BF00718620. Virchows Arch A Pathol Anat Histopathol. 1989. PMID: 2499093
-
Gonadotropin-releasing hormone initiates multiple signaling pathways in human GH-secreting adenomas.J Endocrinol Invest. 2004 Apr;27(4):328-33. doi: 10.1007/BF03351057. J Endocrinol Invest. 2004. PMID: 15233551
-
Human growth hormone and prolactin secreting pituitary adenomas analyzed by in situ hybridization.Am J Pathol. 1989 Mar;134(3):605-13. Am J Pathol. 1989. PMID: 2466405 Free PMC article.
-
Somatostatin cells in human somatotropic adenomas.Virchows Arch A Pathol Anat Histopathol. 1992;420(1):95-101. doi: 10.1007/BF01605990. Virchows Arch A Pathol Anat Histopathol. 1992. PMID: 1347188
-
Effect of 4 weeks of octreotide treatment on prolactin, thyroid stimulating hormone and thyroid hormones in acromegalic patients. A double blind placebo-controlled cross-over study.J Endocrinol Invest. 1995 Dec;18(11):840-6. doi: 10.1007/BF03349830. J Endocrinol Invest. 1995. PMID: 8778155 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical